Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
06990
Company Profile
Business description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world’s prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
Contact
No. 666 Xinhua Avenue
Chengdu Cross-Strait Science and Technology Industry Development Park
Wenjiang
Sichuan
Chengdu
CHNSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,870
Stocks News & Analysis
stocks
3 Warren Buffett stocks to avoid today
These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks
Should you invest in small caps?
With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio.
stocks
Strong second half anticipated for ASX mining play
A more focused business model should benefit the company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,079.20 | 17.70 | 0.20% |
| CAC 40 | 7,870.68 | 75.26 | 0.97% |
| DAX 40 | 23,739.47 | 204.64 | 0.87% |
| Dow JONES (US) | 46,247.29 | 299.97 | 0.65% |
| FTSE 100 | 9,284.83 | 70.85 | 0.77% |
| HKSE | 26,128.20 | 356.48 | -1.35% |
| NASDAQ | 22,484.07 | 99.37 | 0.44% |
| Nikkei 225 | 45,354.99 | 399.94 | -0.87% |
| NZX 50 Index | 13,111.73 | 42.06 | -0.32% |
| S&P 500 | 6,643.70 | 38.98 | 0.59% |
| S&P/ASX 200 | 8,787.70 | 13.20 | 0.15% |
| SSE Composite Index | 3,828.11 | 25.20 | -0.65% |